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Abstract
Formation of amyloid-like fibrils is involved in numerous human protein deposition diseases, but is also an intrinsic property
of polypeptide chains in general. Progress achieved recently now allows the aggregation propensity of proteins to be
analyzed over large scales. In this work we used a previously developed predictive algorithm to analyze the propensity of
the 34,180 protein sequences of the human proteome to form amyloid-like fibrils. We show that long proteins have, on
average, less intense aggregation peaks than short ones. Human proteins involved in protein deposition diseases do not
differ extensively from the rest of the proteome, further demonstrating the generality of protein aggregation. We were also
able to reproduce some of the results obtained with other algorithms, demonstrating that they do not depend on the type
of computational tool employed. For example, proteins with different subcellular localizations were found to have different
aggregation propensities, in relation to the various efficiencies of quality control mechanisms. Membrane proteins,
intrinsically disordered proteins, and folded proteins were confirmed to have very different aggregation propensities, as a
consequence of their different structures and cellular microenvironments. In addition, gatekeeper residues at strategic
positions of the sequences were found to protect human proteins from aggregation. The results of these comparative
analyses highlight the existence of intimate links between the propensity of proteins to form aggregates with b-structure
and their biology. In particular, they emphasize the existence of a negative selection pressure that finely modulates protein
sequences in order to adapt their aggregation propensity to their biological context.
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Introduction
The conversion of peptides and proteins into insoluble fibrillar
aggregates is the hallmark of ca. 40 human diseases [1–2]. It is now
clear, however, that the formation of such well-organized fibrillar
aggregates, generally referred to as amyloid fibrils when deposition
occurs extracellularly, is not a characteristic of the few unfortunate
sequences associated with protein deposition diseases, but a generic
property of polypeptide chains [3]. This novel concept has raised the
question as to how protein aggregation is prevented effectively in
living organisms. Molecular chaperones and several dedicated
cellular quality control mechanisms can fulfill this requirement [4–
5]. However, it has also emerged that proteins have evolved
numerous sequence and structural adaptations to counteract their
natural tendency to aggregate into amyloid-like fibrils [6].
The generality of amyloid fibril formation has also suggested that
this phenomenon may be governed by simple and rationalizable
physicochemical factors, leading to the development of algorithms
capable of predicting aggregation parameters of unstructured
polypeptides directly from their amino acid sequence [7–14].
Computational methods based on atomistic description and/or
molecular dynamics were also developed [15–20]. These algorithms
have the potential to predict a number of aggregation-related
parameters,includingthe aggregation rateoraggregation propensity
of a polypeptide chain, the regions of the sequence that promote
aggregation and the effect of mutations on the aggregation behavior.
The simplicity of the sequence-based algorithms allowed their
application to the systematic analysis of all the protein sequences
composing the proteomes of one or more living organisms [21–
25]. By using this strategy, Serrano and co-workers demonstrated
that intrinsically disordered proteins have a lower aggregation
propensity than globular proteins [21]. The same group also
showed that in proteins from E. coli positions flanking aggregation-
promoting regions are enriched with residues with a low
aggregation propensity, such as proline, arginine, lysine, glutamate
and aspartate [22]. Interestingly, when the analysis is restricted to
the most highly aggregation-promoting regions, only proline,
lysine and arginine become dominant at these flanking positions
[22]. The over-representation of such residues at these positions
can result from their physicochemical properties, as well as from
the ability of E. coli co-translational chaperones to recognize them
when associated with hydrophobic stretches [22].
In another work the entire proteomes of D. melanogaster, S.
cerevisiae and C. elegans were analyzed [23]. Proteins normally
forming oligomeric complexes were found to have an aggregation
score lower than those operating in a free form in all three
organisms [23]. This was explained by considering that oligomer-
forming proteins are at risk for aggregation as they constantly
interact with other polypeptide chains. In addition, essential
proteins were found to have a lower aggregation score than non-
essential proteins, emphasizing the evolutionary pressure that has
acted on the former to minimize their aggregation propensity [23].
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co-workers demonstrated that the average aggregation propensity
of a proteome correlates inversely with the complexity and
longevity of the related organism, underlining the importance of
studying each organism independently [24]. The same authors
found that in the proteome of the yeast S. cerevisiae proteins with
different functions, as well as proteins featuring different
subcellular localizations, have very different aggregation potentials
[25].
In this work we use a previously developed algorithm [8,11,26]
to analyze the 34,180 protein sequences of the human proteome.
The algorithm is based on simple characteristics of the primary
sequence, such as hydrophobicity, b-sheet propensity and charge,
previously recognized to be important determinants of the
aggregation process [7]. It predicts the fibril elongation rate of
an initially unstructured polypeptide chain as well as the regions of
the sequence that promote its aggregation, and has been
extensively validated against experimental data [8,11,26]. This
algorithm represents therefore a valid and straightforward
computational tool to quantify the intrinsic aggregation propen-
sities of a large quantity of protein sequences and identify the
aggregation-promoting regions within them.
The application of this computational tool to the human
proteome enabled us to recognize unprecedented features,
including an inverse correlation between aggregation propensity
and protein length, and a discrepancy between the aggregation
propensities of proteins taking the secretory pathway (operating in
the endoplasmic reticulum, Golgi apparatus, lysosomes and
extracellular media) and those operating in other intracellular
compartments (nucleus, mitochondria, ribosomes, cytoskeleton).
We were also able to reproduce some of the results obtained with
other algorithms, demonstrating that the results obtained do not
depend on the type of computational tool employed, and cross-
validating the different existing algorithms. In addition, the
previously published results have in general been obtained by
studying prokaryotes like E. coli or low-complexity eukaryotes like
S. cerevisiae, whereas our analysis focuses entirely on the human
proteome. Our results also show that different structural
subpopulations of the human proteome have actually different
average aggregation propensities, whereas proteins involved in
protein deposition diseases do not differ extensively from the
human proteome taken at a whole in terms of aggregation
propensity. Taken together, these results lend further support to
the view that modulation of the aggregation propensity has been a
driving force in protein evolution. It also helps identify the
categories of human proteins that are at risk for aggregation and
need a more strict control by the cellular machinery.
Results/Discussion
Determination of the Aggregation Propensity of All
Proteins from the Human Proteome
We have used a predictive algorithm [11,26] to calculate the
aggregation propensity of every protein sequence of the human
proteome. A set of parameters were calculated for each of the
34,180 sequences (Figure 1; see also Methods, Protocol S1, and
Figure S2):
– the average aggregation propensity of the sequence (Z
agg) and
the intrinsic aggregation propensity profile (Zprof
agg), i.e. the
variation of aggregation propensity across the sequence;
– the frequency of the aggregation peaks (f
peaks), i.e. the number
of stretches of at least 3 consecutive residues with an
aggregation propensity Zi
agg higher than 1, divided by the
number of residues in the sequence;
– the average length of all the aggregation peaks present in the
sequence (L
peaks);
– the area of each aggregation peak, i.e. the surface under the
peak that lies above the threshold of Zi
agg=1 (S
agg); S
agg was
then normalized by both the protein length (S
agg/L
protein) and
the number of peaks (S
agg/N
peaks).
All membrane intrinsic proteins (5,279 sequences) were
removed from the database and analyzed separately, as they
differ significantly from the non-membrane proteins in terms of
charge and hydrophobicity [27], parameters that are preponder-
ant in determining the aggregation propensity of a protein [7].
The distributions of the aggregation parameters over the human
proteome cleared from the membrane protein were analyzed (see
Figure S1). The protein length (L
protein) and the aggregation
propensity (Z
agg) have a log-normal and a normal distribution,
Figure 1. Definition of the aggregation parameters calculated
for a sequence. The aggregation propensity profile and the
parameters shown in the figure refer to the peptide A-Dan, used here
as an example. Red area: surface of the aggregation peaks (S
agg); green:
flanking positions.
doi:10.1371/journal.pcbi.1000199.g001
Author Summary
Amyloid-like fibrils are insoluble proteinaceous fibrillar
aggregates with a characteristic structure (the cross-b
core) that form and deposit in more than 40 pathological
conditions in humans. These include Alzheimer’s disease,
Parkinson’s disease, type II diabetes, and the spongiform
encephalopathies. A number of proteins not involved in
any disease can also form amyloid-like fibrils in vitro,
suggesting that amyloid fibril formation is an intrinsic
property of proteins in general. Recent efforts in under-
standing the physico-chemical grounds of amyloid fibril
formation has led to the development of several algo-
rithms, capable of predicting a number of aggregation-
related parameters of a protein directly from its amino acid
sequence. In order to study the predicted aggregation
behavior of the human proteome, we have run one of
these algorithms on the 34,180 human protein sequences.
Our results demonstrate that molecular evolution has
acted on protein sequences to finely modulate their
aggregation propensities, depending on different param-
eters related to their in vivo environment. Together with
cellular control mechanisms, this natural selection protects
proteins from aggregation during their lifetime.
Human Proteome Aggregation
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peaks, L
peaks, S
agg/L
protein and S
agg/N
peaks
parameters do not have well-defined distributions, but approxi-
mate to log-normal distributions when proteins devoid of
aggregation peaks are not taken into account.
Longer Proteins Have Less Pronounced Aggregation
Peaks
We first looked at the dependence of the aggregation
parameters on protein length (Figure 2). When the aggregation
propensities Z
agg of all the non-membrane proteins of the human
proteome are plotted against their lengths in amino acid residues,
no significant correlation is apparent (Figure 2A). To limit the
influence of the outlying longest proteins on the x
2 calculation of
the linear correlation, polypeptide chains longer than 3,000
residues (0.6% of the proteome) were excluded from the analysis.
In addition, for each protein length interval of 50 residues, a single
Z
agg value was determined as the average value of all proteins
falling in that interval. This allows the different intervals to have
similar weights in the correlation, regardless of the number of
proteins present in each case. Following these procedures, no
correlation is found between Z
agg and protein length (Figure 2B).
The absence of correlation persists when different interval lengths
or length thresholds are used for the analysis. Similarly to Z
agg, the
frequency of aggregation peaks (f
peaks) and their average length
(L
peaks) do not change with protein length (Figure 2C and 2D). On
the contrary, the total surface of the aggregation peaks normalized
either by the protein length (S
agg/L
protein) or by the number of
peaks (S
agg/N
peaks), correlate inversely with protein length
(Figure 2E and 2F). The R and p values obtained by analyzing
the plots with a best-fitting procedure and a linear function
indicate that such correlations are significant (Figure 2E and 2F).
However, the dependence of S
agg/L
protein and S
agg/N
peaks on
protein length seems to be rather exponential or hyperbolic
(Figure 2E and 2F). Again, these results appear to be robust and
independent of the calculation method. From this analysis it can
be concluded that long proteins have, on average, less effective
aggregation-promoting regions than those present in short ones.
These results imply that while aggregation-prone residues are
present to similar extents in long and short proteins, their
clustering within short segments of the sequence is less pronounced
in long proteins. This feature has been demonstrated to be an
important determinant of the aggregation rate of a model
unstructured polypeptide chain [26], as well as of a set of proteins
(G-G. Tartaglia and M. Vendruscolo, personal communication).
For example, in apoMb1–29, a model unstructured polypeptide
that encompasses the first 29 residues of horse heart apomyoglo-
bin, the clustering of aggregation-prone residues in a narrow
region of the sequence was found to enhance dramatically the
aggregation rate [26]. Why have long proteins evolved to have less
pronounced aggregation peaks and, as a consequence, slower
aggregation rates? Reduced aggregation peaks could counteract
the fact that long proteins have, with respect to short ones, pI
closer to neutrality [28], a higher number of stretches of
alternating hydrophobic-hydrophilic residues [29], and slower
folding rates [30]. All these features have indeed been demon-
strated to increase the aggregation propensity of an unstructured
polypeptide [7,31–33].
Interestingly, it has been shown that two major cytosolic
mammalian chaperones, namely Hsc70 and the chaperonin TriC,
interact preferentially with large proteins [34]. A large fraction of
the Hsc70 protein substrates is heavier than 50 kDa [34]. The
chaperonin TRiC interacts predominantly with proteins between
30 and 60 kDa, but also with several larger proteins, with the
2000-residue myosin heavy chain representing its heavier
identified substrate [34–35]. It is noteworthy that the lower size
limits of Hsc70 and TriC substrates correspond approximately to
the inflection points of the exponential dependences of the
parameters S
agg/L
protein and S
agg/N
peaks on protein length
(Figure 2E and 2F). In eukaryotes long proteins also tend to be
expressed at lower levels than short ones [36–37], which reduces
their local concentration and thus their susceptibility to aggregate.
This comparative analysis suggests that diverse complementary
mechanisms could have been developed through evolution to
counteract the particular susceptibility of long proteins to
aggregate. In addition to an assisted folding by chaperones and
reduced expression levels, our results show that long protein
sequences themselves have probably been constrained by evolu-
tion to reduce their intrinsic aggregation propensity, through an
attenuation of their aggregation-prone regions.
Proteins with Different Subcellular Localization Have
Different Aggregation Propensities
We then compared the distributions of the various aggregation
parameters in proteins from different subcellular localizations
(Figures 3 and 4; Table 1, lines 1–8). Membrane proteins were
excluded from the analysis. Subcellular localizations can be
divided in two groups. The proteins that take the secretion
Figure 2. Dependence of the aggregation parameters on
protein length. (A) All proteins are reported with their individual
values of Z
agg and protein length. For graphical convenience, the log of
the protein length is represented. (B–F) Each point represents the
average value over all the sequences having a length comprised in an
interval of 50 residues. The membrane proteins are excluded from all
the analyses reported in the figure. Solid lines (E–F) represent the best
fits to an exponential function. The sizes of the substrates typically
targeted by the chaperones Hsc70 and TriC [34–35] are indicated as
horizontal solid lines (E–F).
doi:10.1371/journal.pcbi.1000199.g002
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membrane proteins taken as a whole (Figure 3; Figure 4A–4E;
Table 1, lines 1–4). Indeed, all the aggregation parameters of
proteins from the endoplasmic reticulum, the extracellular media
and the lysosomes are systematically higher than the ones of the
human non-membrane proteins in general (Figure 4A–4E;
Table 1, lines 1,3,4). None of the proteins from the endoplasmic
reticulum and the lysosomes and only 0.6% of the proteins from
the extracellular media are devoid of aggregation peaks (Figure 3).
Golgi proteins are also more prone to aggregate than human non-
membrane proteins (Figure 3; Figure 4A–4E; Table 1, line 2). In
this case the discrepancy is less marked, probably due to the lower
amount of sequences analyzed. On the contrary, intracellular
districts like the nucleus, cytoskeleton and ribosomes contain
proteins with particularly low propensities to aggregate, according
to every parameter analyzed (Figure 3; Figure 4F–4J; Table 1,
lines 6–8). The case of the mitochondria is intermediate between
these two cases (Figure 4F–4J; Table 1, line 5). The peculiarity of
this organelle in terms of aggregation propensity may reflect its
prokaryotic origin. To exclude a possible bias due to the presence
of specific signal peptides in the protein sequences of some
compartments, the analysis was repeated after removing signal
peptides from the protein sequences contained in our databases
(see Methods). This correction did not modify the above-
mentioned results (Table 1, lines 1–8).
How can the discrepancy between proteins taking the secretion
pathway and proteins confined to the intracellular media be
explained? Since proteins targeted for secretion or for other
cellular compartments on the way to secretion operate in areas
where chaperones are poorly represented, several strict quality
control mechanisms check whether such proteins are properly
folded or not [5,38]. This high level of extrinsic cellular control
balances and enables proteins with high intrinsic aggregation
propensities. On the contrary, in E. coli, periplasmic proteins have
Figure 3. Percentages of proteins without aggregation peaks in
different populations. The number of sequences composing each
population is given in parentheses.
doi:10.1371/journal.pcbi.1000199.g003
Figure 4. Cumulative distributions of the aggregation param-
eters in populations regrouping proteins from different
subcellular localizations. Black: proteome without membrane
proteins (28,901 sequences); purple: proteins from the endoplasmic
reticulum (331 sequences); dark blue: proteins from the Golgi apparatus
(93 sequences); light blue: proteins from the extracellular media (499
sequences); green: proteins from lysosomes (113 sequences); grey:
mitochondrial proteins (667 sequences); yellow: nuclear proteins (4,898
sequences); orange: proteins of the cytoskeleton (456 sequences); red:
ribosomal proteins (163 sequences). The membrane proteins were
excluded from all the subcellular populations analyzed.
doi:10.1371/journal.pcbi.1000199.g004
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cytoplasmic ones, in relation to the paucity of quality control
machineries and molecular chaperones in the bacterial periplasm
[39]. The differences observed in the aggregation propensities of
proteins from different compartments can also partially reflect the
different proportions of intrinsically disordered proteins in these
compartments (see below; [40]), or differences in the conditions in
which proteins fold. Different organelles can differ in terms of pH,
redox potential, presence of proteases, molecular crowding, and
types and abundance of chaperones [41–42]. In particular, it has
been shown experimentally that the nuclear compartment creates
an environment that renders proteins more prone to denaturate
[42–43], which is in good agreement with our data. Thus, protein
sequences would be precisely adapted to the conditions in which
they evolve in vivo.
Remarkably, using a different predictive algorithm applied on
the proteome of the yeast S. cerevisiae, Tartaglia and colleagues
ordered the subcellular areas according to the b-aggregation
propensity of their proteins and obtained the same ranking [25].
The agreement between these two analyses on evolutionary distant
eukaryotic organisms, such as S. cerevisiae and H. sapiens,
emphasizes the generality of the observed phenomena. Evolution
seems to have modulated the average aggregation propensities of
different subcellular areas in a similar manner in such distantly
related organisms.
Membrane Proteins, Intrinsically Disordered Proteins, and
Folded Proteins Have Different Aggregation Propensities
We performed the same comparative analysis on different
populations of the human proteome. Membrane proteins have
significantly higher values of every aggregation parameter
analyzed than the whole human proteome (Figure 5A–5E;
Table 1, line 9). Moreover, only 0.3% of membrane proteins do
not contain aggregation peaks, whereas this fraction rises to 7.9%
for the whole human proteome (Figure 3). Thus, membrane
proteins constitute a very distinct and peculiar group.
The intrinsically disordered proteins form another distinct
group. In our analysis we considered proteins or protein segments
(.40 residues) that were experimentally shown to be intrinsically
disordered (43 sequences; see Methods for details). For all the
parameters studied, the values of the intrinsically disordered
proteins were particularly low, and significantly lower than the
corresponding parameters from the reference database (Figure 5A–
5E; Table 1, line 10). A majority of them (63%) do not contain any
aggregation peak at all (Figure 3).
We then used the SCOP-derived database ASTRAL40 [44] to
have an experimentally determined population of folded human
proteins (1,391 sequences). Proteins from the ASTRAL40
database have higher values of Z
agg, f
peaks and S
agg/L
protein than
the reference database, most probably due to the significant
proportion of intrinsically disordered proteins in the latter
Table 1. Comparisons between the aggregation parameters in different populations.
Analyzed population Reference population L
protein Z
agg f
peaks L
peaks S
agg/L
protein S
agg/N
peaks
Endoplasmic reticulum
a all except membrane proteins +++ +++ +++ +++ +++ +++
Golgi apparatus
a all except membrane proteins +++ n.s. n.s. +++ n.s.
c ++
Extracellular media
a all except membrane proteins 222 +++ +++ +++ +++ +++
Lysosomes
a all except membrane proteins +++ +++ +++ +++ +++ +++
Mitochondria
a all except membrane proteins 222 +++ +++ 22 n.s.
c 22
Nucleus
a all except membrane proteins +++ 222 222 222 222 222
Cytoskeleton
a all except membrane proteins +++ 222 222 222 222 222
Ribosomes
a all except membrane proteins 222 222 222 222 222 222
Membrane proteins all +++ +++ +++ +++ +++ +++
Intrinsically disordered proteins all except membrane proteins 222 222 222 222 222 222
Folded proteins all except membrane proteins 222 +++ +++ 222 +++ 222
Proteins forming fibrillar aggregates in vivo
b all except membrane proteins 2 +++ ++ n.s. +
d n.s.
Proteins from the extracellular media forming
fibrillar aggregates in vivo
b
extracellular media 222 +
d n.s. n.s. n.s. 22
Proteins from the cytoskeleton forming
fibrillar aggregates in vivo
b
cytoskeleton n.s. n.s. n.s. n.s. n.s. 2
d
Folded proteins forming fibrillar aggregates
in vivo
b
folded proteins n.s. n.s. n.s. n.s. n.s. n.s.
Folded proteins forming fibrillar aggregates
in vitro
folded proteins 2 n.s. n.s. n.s. n.s. n.s.
The distributions of the aggregation parameter values of the analyzed population are compared to the ones of the reference population using statistical tests (see
Methods).
+++ and 222 indicate that the analyzed population has a distribution significantly (p,0.001) shifted to higher or lower values than the reference population in the
statistical tests performed, respectively. ++ and 22,i d e m( p ,0.01). + and 2,i d e m( p ,0.05).
n.s., the distributions of the analyzed and reference populations are not significantly different (p.0.05).
aThe results remain unchanged when the sequences without signal peptides of the corresponding subcellular districts (membrane proteins excluded) are compared
with a reference database composed of all the human non-membrane protein sequences without the identified signal peptides.
bProteins forming amyloid fibrils and intracellular inclusions with amyloid-like characteristics.
cThe distributions of the two populations differ significantly although their median values are not significantly different (significant differences in the Kolmogorov-
Smirnov test and not in the Mann-Whitney test).
dThe difference was significant in the Mann-Whitney test but not in the Kolmogorov-Smirnov test (parameter lacking a defined distribution).
doi:10.1371/journal.pcbi.1000199.t001
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proteins have all aggregation parameters significantly higher than
intrinsically disordered proteins (Figure 5A–5E). Linding and co-
workers also compared intrinsically folded and disordered proteins
[21]. The analysis was performed with a different algorithm for the
prediction of b-aggregation, using only experimentally character-
ized proteins and with no restriction on the organism of origin
[21]. Following this approach these authors obtained a similar
separation between intrinsically folded and disordered proteins,
and similar values for the frequency of aggregation-prone regions
and percentage of proteins without aggregation-prone regions in
these two populations [21].
The differences in the aggregation propensities between the
membrane, folded and intrinsically disordered proteins could
possibly arise from their different structures. In membrane proteins,
pronounced aggregation peaks are perfectly soluble in the lipid
bilayer, as they are mostly hydrophobic [45]. Folded proteins can
also tolerate aggregation-prone regions, because such segments are
generally buried in the hydrophobic core of the protein, and thus
protected from inter-molecular interactions [6,21,46]. On the
contrary, intrinsically disordered polypeptides expose the whole
backbone to the solvent, and thus need peculiar sequence
adaptations to reduce their aggregation propensities [6,47].
Fibril Forming Proteins Do Not Differ Extensively from
the Other Human Proteins
Proteins that were found to form amyloid fibrils or structurally
related intracellular inclusions in the context of human protein
deposition diseases were also analyzed (31 sequences; see Protocol
S1 for a list). Proteins containing a poly-Gln stretch like huntingtin
were excluded from this list, as they aggregate through a different
mechanism [48]. Disease-related proteins are not found to be
systematically different from the other human non-membrane
proteins. Their Z
agg and f
peaks values are significantly higher than
those of the reference database (Figure 5F–5G; Table 1, line 12).
However, the distributions of L
peaks and S
agg/N
peaks are not
significantly different (Figure 5H and 5J; Table 1, line 12). The
distributions of S
agg/L
protein differ to some extent, but we cannot
exclude that such difference arises from the shorter average length
of disease-related proteins with respect to the reference proteins
(Figure 5I; Table 1, line 12).
As described above proteins, from different subcellular com-
partments have different aggregation propensities. We thus
compared groups of proteins forming fibrillar aggregates in vivo
with proteins from the corresponding subcellular districts. This
was performed on fibril-forming proteins from the extracellular
media (23 sequences; Table 1, line 13) and from the cytoskeleton
(3 sequences; Table 1, line 14), comparing them with all
extracellular and cytoskeleton proteins, respectively. In these two
comparative analyses the differences between proteins forming
fibrils in vivo and corresponding human proteins are not
significant (Table 1, lines 13–14). Similar comparative analyses
could not be carried out for the other subcellular compartments as
the numbers of fibril-forming sequences were insufficient for
statistical analyses.
Finally, we compared the folded proteins associated with
diseases (15 sequences; see Protocol S1 for a list) with the
reference database of folded human proteins (ASTRAL40). None
of the aggregation parameters appeared to be significantly
different (Figure 5F–5I; Table 1, line 15). Similarly, 10 non-
disease folded proteins shown to form amyloid-like fibrils in vitro
(see Protocol S1 for a list) do not differ for any of the aggregation
parameters from the folded proteins of the ASTRAL40 database
(Table 1, line 16).
All these analyses support the view that no fundamental
differences exist in terms of intrinsic aggregation propensity
between proteins related to protein deposition diseases and the
remainder of the human proteome. This result cannot be due to
Figure 5. Cumulative distributions of the aggregation param-
eters in different populations. Grey: all proteome (34,180 sequenc-
es); pink: membrane proteins (5,279 sequences); black: proteome
without membrane proteins (28,901 sequences); green: folded proteins
(ASTRAL40 database; 1,391 sequences); blue: intrinsically disordered
proteins (43 sequences); red: proteins forming amyloids or related
intracellular inclusions in vivo and associated with human diseases (31
sequences); orange: folded proteins forming amyloids or related
intracellular inclusions in vivo and associated with human diseases
(15 sequences).
doi:10.1371/journal.pcbi.1000199.g005
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aggregation propensities of two populations of proteins when they
actually exist, as demonstrated by the remarkable discrepancies
observed between proteins from different subcellular compart-
ments (Figure 4) and between membrane, folded and intrinsically
disordered proteins (Figure 5). On the contrary, this finding
explains why proteins that are not associated with recognized
protein deposition diseases also have an inherent ability to form
amyloid-like fibrils in vitro [3,49]. It also suggests that the reason
why only a limited number of human proteins give rise to protein
deposition diseases has to be sought in the biology of such proteins,
rather than in specific traits dictated by their amino acid
sequences. These concepts have been proposed for the first time
almost a decade ago following individual experimental observa-
tions [3]. The result obtained here at the genomic scale is a strong
argument to support them.
Human Proteins Have Evolved To Secure Gatekeeper
Residues at Positions Flanking the Peaks
We analyzed the amino acid composition in the aggregation
peaks, their flanks, i.e. the regions of the sequence immediately
preceding and following the peaks (see Methods for an accurate
definition of the flanks) and the rest of the sequence (‘‘valleys’’). As
expected, residues with high intrinsic aggregation propensity, like
Trp, Phe, Tyr, Cys, Val, Ile and Leu, are mostly found inside the
peaks, whereas residues with low aggregation propensity, like Pro,
Arg, Lys, Asp and Glu, are poorly represented in the peaks
(Figure 6A). The latter are particularly highly represented at the
flanks, where they are more frequent than in both the peaks and
valleys (Figure 6A). On the contrary, residues with high intrinsic
aggregation propensity are poorly represented at the flanks and
even less frequent than in the valleys (Figure 6A). Thus, our
definition of flanks corresponds to a portion of the protein
sequences with a very specific amino acid residue composition.
Strikingly, the relative distributions of Pro, Arg, Lys, Asp and
Glu at the flanking positions change with peak length. While Pro,
Arg and Lys frequencies at the flanks increase significantly with
peak length, Asp and Glu frequencies decrease (Figure 6B).
Rousseau and colleagues obtained similar results on the E. coli
proteome, using TANGO as a predictive algorithm of b-
aggregation propensity [22]. The full agreement between the
two algorithms, even after a fine analysis such as the frequency of
specific residues at flanking positions and their dependence on
peak length, offers a cross-validation of both computational
methods and underlines the generality of the observation.
Thus, our results confirm the role of Pro, Arg and Lys as
‘‘gatekeeper residues’’ at the flanks of the aggregation peaks,
protecting proteins with particularly extended peaks from
aggregation. This specific role of these residues can be rational-
ized. Pro is conformationally constrained and thus an efficient
breaker of b-structures. Arg and Lys are charged, and their long
and flexible side-chains make the aggregation process entropically
disadvantageous. Moreover, Arg and Lys have been shown to be
specifically recognized by the most common chaperones when
associated with hydrophobic stretches (reviewed in [22]).
Conclusions
The analysis of the human proteome presented here has
revealed that protein sequences have been constrained by
evolution to finely modulate their aggregation propensity depend-
ing on their length, subcellular localization, and conformation. It
has revealed a striking synergy between the evolution of protein
sequences and biology. Modulation of the intrinsic aggregation
propensity of protein sequences by molecular evolution on the one
hand, and cellular protective mechanisms on the other hand, act
as complementary strategies to prevent proteins to aggregate
during their lifetime. The opportunities offered by a bioinformatics
approach that uses experimentally tested and cross-validated
algorithms are enormous. They will offer in the future new
strategies not just to understand the link between protein
aggregation and evolution, but also to learn the ‘‘tricks’’ set up
by Nature to effectively control protein aggregation in highly
crowded environments of living organisms.
Methods
Datasets
All the datasets cited in this work are available as Protocol S1 or
upon request. The ‘‘entire human proteins’’ dataset has been
downloaded from the ftp site of the National Center for
Biotechnology Information (NCBI) as fasta-formatted translations
of an mRNA collection (RefSeq database). The ‘‘intrinsically
disordered proteins’’ dataset has been extracted as fasta-formatted
sequences from the Database of Protein Disorder (DisProt), release
3.5 [50] using ‘‘homo sapiens’’ as a keyword for the ‘‘search by
source organism’’ filter. Swiss-Prot based accession numbers were
synchronized with the ‘‘entire human proteins’’ dataset (with
NCBI based protein identifiers, GIs) with automated local BLAST
searches [51]. The dataset was then adjusted to include both fully
disordered proteins and non-redundant non-overlapping protein
fragments of length .40 residues extracted from full sequences of
partially disordered proteins. The ‘‘verified structured proteins’’
Figure 6. Gatekeeper residues in the human proteome. (A)
Amino acid frequencies at different positions, relative to their global
frequencies in the human proteome. A relative frequency of 1.0 for a
given residue at a given position means that the residue occupies that
position with a frequency identical to that in the whole human
proteome. Black: inside the aggregation peaks; grey: at the flanking
positions; white: outside the aggregation peaks and far from the flanks
(‘‘valleys’’). (B) Dependence of the frequencies of the gatekeepers at the
flanks on the length of the aggregation peak. Filled circles: average
frequencies of Pro, Arg and Lys; empty circles: average frequencies of
Asp and Glu. The membrane proteins are removed from the database.
doi:10.1371/journal.pcbi.1000199.g006
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ASTRAL40 database, release 1.71 [44]. Each protein in this
dataset shares less than 40% sequence identity with all other
proteins.
Information on protein subcellular localization has been
extracted from Gene Ontology (GO) annotations [52]. Subgroups
were constructed according to the following GO terms: integral to
membrane (GO:0016021; 5279 sequences), lysosomes
(GO:0005764; 113 sequences), nucleus (GO:0005634; 4898
sequences), mitochondria (GO:0005739; 667 sequences), Golgi
apparatus (GO:0005794; 93 sequences), endoplasmic reticulum
(GO:0005783; 331 sequences), cytoskeleton (GO:0005856; 456
sequences), ribosomes (GO:0005840; 163 sequences) and extra-
cellular media (GO:0005615; 499 sequences).
In a second time, all the above-mentioned datasets were rebuilt
by removing signal peptides as a possible source of bias due to
their peculiar amino acid composition. The position and extension
of the signal peptides were taken, when available, from NCBI
Protein database by an automatic and systematic analysis of
protein annotations.
Other datasets include: proteins forming amyloid fibrils or
intracellular inclusions with amyloid-like characteristics, all related
to protein deposition diseases (with the exception of proteins
containing a poly-Gln segment as they aggregate through a
different mechanism); a subpopulation of these proteins containing
only the folded ones; proteins forming amyloid-like fibrils in vitro,
but unrelated to protein deposition diseases. These databases have
been constructed by extensive search in literature and are listed in
Protocol S1.
Determination of Aggregation Parameters
The parameters Z
agg, Zprof
agg, f
peaks, L
peaks and S
agg have been
determined for each protein sequence as described in Protocol S1,
and previously [11,26].
Flanking Regions and Gatekeepers
The definition of flanking regions has been accurately refined by
a recursive procedure aimed at avoiding overlaps of flanks with
neighbor peaks. The algorithm we used has two parameters for
defining both the position (F
p) and length (F
l) of the flank. Given a
region of the sequence defined as the pattern oooooo^^^^^oooooo,
(^=residue with zi
agg$1, o=residue with zi
agg,1), F
p defines the
starting position of the flank from both extremities of the peak and
F
l defines the length of the flank at both extremities. The
optimized values were found to be F
p=23 (the flanks start from
the residue o that is 3 residues distant from the first, or last, residue
^) and F
l=3 (see Figure 1, or consider the pattern
oooooo^^^^^oooooo, where flanks are underlined). These values
were valid for peaks of every length.
Amino acid compositions of peaks, flanks, peaks-free regions
and whole sequence were calculated, for each naturally occurring
amino acid, according to:
Fp
r ~ 100
Lp
P p
j~1
nr,j Ff
r ~ 100
Lf
P f
j~1
nr,j Fg
r ~ 100
Lg
X g
j~1
nr,j ð1Þ
where Fr
p, Fr
f, Fr
g are the percentages of the r
th amino acid residue
in peaks, flanks and global respectively; p, f and g are the number
of peaks, flanks and protein, respectively; and L
p ,L
f and L
g are the
total peak, flank and protein length calculated over the whole
dataset, respectively.
Statistics
The distributions of the aggregation parameters of two different
protein populations were compared using the Student, Mann-
Whitney and Kolmogorov-Smirnov tests for Z
agg and the log of
L
protein (normal distributions), and Mann-Whitney and Kolmo-
gorov-Smirnov tests for the other parameters studied (f
peaks, L
peaks,
S
agg/L
protein and S
agg/N
peaks).
Some of the parameters studied have a log-normal distribution,
and have to be statistically analyzed in a different way than
parameters with a normal distribution. For a normally distributed
parameter X, the interval m(X)6SD(X) (where m(X) and SD(X) are
the arithmetic mean and associated standard deviation of X,
respectively) covers a probability of 68.3%. For a parameter Y
having a log-normal distribution, the same probability is covered
by m[log(Y)]6SD[log(Y)] or by m*(Y) N/SD*(Y), where m*(Y)=
e
m[log(Y)] is the geometric mean of Y, SD*(Y)=e
SD[log(Y)] is the
multiplicative standard deviation of Y, and N/means ‘‘times/
divided by’’. The importance of log-normal distributions in
biology and the way to analyze them were previously discussed
[53].
Supporting Information
Figure S1 Distributions of the aggregation parameters in the
human proteome. All the non-membrane proteins are considered
in the analysis (28,901 sequences). For parameters that do not have
a normal distribution, their log-normal distribution is given in
insets.
Found at: doi:10.1371/journal.pcbi.1000199.s001 (1.43 MB TIF)
Figure S2 Independence of magg (A) and sagg (B) on protein
length.
Found at: doi:10.1371/journal.pcbi.1000199.s002 (0.22 MB TIF)
Protocol S1 Supporting Information
Found at: doi:10.1371/journal.pcbi.1000199.s003 (0.12 MB RTF)
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